TRIM5α Does Not Affect Simian Immunodeficiency Virus SIVmac251 Replication in Vaccinated or Unvaccinated Indian Rhesus Macaques following Intrarectal Challenge Exposure

ABSTRACT TRIM5α is a natural resistance factor that binds retroviral capsid proteins and restricts virus replication. The B30.2/SPRY domain of TRIM5α is polymorphic in rhesus macaques, and some alleles are associated with reduced simian immunodeficiency virus (SIV) SIVmac251 and SIVsmE543 replication in vivo. We determined the distribution of TRIM5α alleles by PCR and sequence analysis of the B30.2/SPRY domain in a cohort of 82 macaques. Thirty-nine of these macaques were mock vaccinated, 43 were vaccinated with either DNA-SIV/ALVAC-SIV/gp120, ALVAC-SIV/gp120, or gp120 alone, and all were exposed intrarectally to SIVmac251 at one of three doses. We assessed whether the TRIM5α genotype of the macaques affected the replication of challenge virus by studying the number of SIV variants transmitted, the number of exposures required, the SIVmac251 viral level in plasma and tissue, and the CD4+ T-cell counts. Our results demonstrated that TRIM5α alleles, previously identified as restrictive for SIVmac251 replication in vivo following intravenous exposure, did not affect SIVmac251 replication following mucosal exposure, regardless of prior vaccination, challenge dose, or the presence of the protective major histocompatibility complex alleles (MamuA01+, MamuB08+, or MamuB017+). The TRIM5α genotype had no apparent effect on the number of transmitted variants or the number of challenge exposures necessary to infect the animals. DNA sequencing of the SIVmac251 Gag gene of the two stocks used in our study revealed SIVmac239-like sequences that are predicted to be resistant to TRIM5α restriction. Thus, the TRIM5α genotype does not confound results of mucosal infection of rhesus macaques with SIVmac251.

[1]  Jeremy Luban,et al.  TRIM5 is an innate immune sensor for the retrovirus capsid lattice , 2011, Nature.

[2]  M. Emerman,et al.  Human Trim5α has additional activities that are uncoupled from retroviral capsid recognition. , 2011, Virology.

[3]  Shiu-Lok Hu,et al.  Evolution of the Antiretroviral Restriction Factor TRIMCyp in Old World Primates , 2010, PloS one.

[4]  T. Shioda,et al.  Multiple sites in the N-terminal half of simian immunodeficiency virus capsid protein contribute to evasion from rhesus monkey TRIM5α-mediated restriction , 2010, Retrovirology.

[5]  B. Haynes,et al.  Low-Dose Mucosal Simian Immunodeficiency Virus Infection Restricts Early Replication Kinetics and Transmitted Virus Variants in Rhesus Monkeys , 2010, Journal of Virology.

[6]  K. Mansfield,et al.  Mucosal Trafficking of Vector-Specific CD4+ T Lymphocytes following Vaccination of Rhesus Monkeys with Adenovirus Serotype 5 , 2010, Journal of Virology.

[7]  Ruchi M. Newman,et al.  TRIM5 Suppresses Cross-Species Transmission of a Primate Immunodeficiency Virus and Selects for Emergence of Resistant Variants in the New Species , 2010, PLoS biology.

[8]  D. Goldstein,et al.  Contributions of Mamu-A*01 Status and TRIM5 Allele Expression, But Not CCL3L Copy Number Variation, to the Control of SIVmac251 Replication in Indian-Origin Rhesus Monkeys , 2010, PLoS genetics.

[9]  T. Shioda,et al.  Anti‐retroviral activity of TRIM5α , 2010, Reviews in medical virology.

[10]  D. Venzon,et al.  Preexisting Infection with Human T-Cell Lymphotropic Virus Type 2 neither Exacerbates nor Attenuates Simian Immunodeficiency Virus SIVmac251 Infection in Macaques , 2010, Journal of Virology.

[11]  J. Sodroski,et al.  TRIM5α Modulates Immunodeficiency Virus Control in Rhesus Monkeys , 2010, PLoS pathogens.

[12]  Alan S. Perelson,et al.  Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1 , 2009, The Journal of experimental medicine.

[13]  D. Fuchs,et al.  CD4+ T-cell loss and delayed expression of modulators of immune responses at mucosal sites of vaccinated macaques following SIVmac251 infection , 2008, Mucosal Immunology.

[14]  K. Reimann,et al.  Deficiency T-cell + Induced by Vaccination during Cd4 T Cells + Infection Afforded by Memory Cd8 Mac251 Immunodeficiency Virus Siv Reduced Protection from Simian , 2008 .

[15]  S. Nisole,et al.  Implication of TRIMalpha and TRIMCyp in interferon-induced anti-retroviral restriction activities , 2008, Retrovirology.

[16]  Hui Li,et al.  Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection , 2008, Proceedings of the National Academy of Sciences.

[17]  C. Aiken,et al.  Proteasomal Degradation of TRIM5α during Retrovirus Restriction , 2008, PLoS pathogens.

[18]  P. Bieniasz,et al.  Generation of Simian-Tropic HIV-1 by Restriction Factor Evasion , 2006, Science.

[19]  A. Engelman,et al.  Proteasome Inhibition Reveals that a Functional Preintegration Complex Intermediate Can Be Generated during Restriction by Diverse TRIM5 Proteins , 2006, Journal of Virology.

[20]  Gary J. Nabel,et al.  Preserved CD4+ Central Memory T Cells and Survival in Vaccinated SIV-Challenged Monkeys , 2006, Science.

[21]  J. Sodroski,et al.  Rapid turnover and polyubiquitylation of the retroviral restriction factor TRIM5. , 2006, Virology.

[22]  T. Hope,et al.  Proteasome inhibitors uncouple rhesus TRIM5alpha restriction of HIV-1 reverse transcription and infection. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[23]  浅岡 健太郎 A retrovirus restriction factor TRIM5α is transcriptionally regulated by interferons , 2006 .

[24]  K. Horie-Inoue,et al.  A retrovirus restriction factor TRIM5alpha is transcriptionally regulated by interferons. , 2005, Biochemical and biophysical research communications.

[25]  David M. Rocke,et al.  Temporal and Anatomic Relationship between Virus Replication and Cytokine Gene Expression after Vaginal Simian Immunodeficiency Virus Infection , 2005, Journal of Virology.

[26]  D. Venzon,et al.  Vaccine-Induced CD8+ Central Memory T Cells in Protection from Simian AIDS , 2005, The Journal of Immunology.

[27]  J. Sodroski,et al.  The Contribution of RING and B-box 2 Domains to Retroviral Restriction Mediated by Monkey TRIM5α* , 2005, Journal of Biological Chemistry.

[28]  A. Yang,et al.  Human Tripartite Motif 5α Domains Responsible for Retrovirus Restriction Activity and Specificity , 2005, Journal of Virology.

[29]  J. Sodroski,et al.  Species-Specific Variation in the B30.2(SPRY) Domain of TRIM5α Determines the Potency of Human Immunodeficiency Virus Restriction , 2005, Journal of Virology.

[30]  C. M. Owens,et al.  Human and Simian Immunodeficiency Virus Capsid Proteins Are Major Viral Determinants of Early, Postentry Replication Blocks in Simian Cells , 2003, Journal of Virology.

[31]  J. Shiver,et al.  Mamu-A*01 Allele-Mediated Attenuation of Disease Progression in Simian-Human Immunodeficiency Virus Infection , 2002, Journal of Virology.

[32]  K. Abel,et al.  The Relationship between Simian Immunodeficiency Virus RNA Levels and the mRNA Levels of Alpha/Beta Interferons (IFN-α/β) and IFN-α/β-Inducible Mx in Lymphoid Tissues of Rhesus Macaques during Acute and Chronic Infection , 2002, Journal of Virology.

[33]  D. Montefiori,et al.  ALVAC-SIV-gag-pol-env-Based Vaccination and Macaque Major Histocompatibility Complex Class I (A*01) Delay Simian Immunodeficiency Virus SIVmac-Induced Immunodeficiency , 2002, Journal of Virology.

[34]  D. Watkins,et al.  A high frequency of Mamu-A*01 in the rhesus macaque detected by polymerase chain reaction with sequence-specific primers and direct sequencing. , 1997, Tissue antigens.

[35]  P. Luciw,et al.  Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection , 1997, Journal of virology.

[36]  Joseph P. Romano,et al.  NASBA technology: isothermal RNA amplification in qualitative and quantitative diagnostics. , 1997, Immunological investigations.

[37]  A. Adachi,et al.  Early replication block of human immunodeficiency virus type 1 in monkey cells. , 1995, The Journal of general virology.